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ABSTRACT
Hypertrophic cardiomyopathy (HOCM) is characterized by heterogeneous clinical expression, unique pathophysiology, and diverse natural history. 
Coexistence of arterial septal defect and partial anomalous pulmonary venous connection (PAPVC) is very rare. Since HOCM is a congenital defect, 
coexistence of other congenital defects should be kept in mind when we treat the patients. Only very few cases of HOCM with coexisting congenital 
anomalies have been reported so far in medical literature. Hence, we report a case of HOCM with atrial septal defect and PAPVC in a 49-year-old male 
patient.
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INTRODUCTION
Hypertrophic cardiomyopathy (HOCM) is a well-known myocardial 
disease caused by a multitude of mutations in genes encoding proteins 
of the cardiac sarcomere [1-5]. HCM is characterized by heterogeneous 
clinical expression, unique pathophysiology, and diverse natural 
history [6-13]. However, the additional coexistence of an atrial septal 
defect (ASD) and partial anomalous pulmonary venous connection 
(PAPVC) is quite rare. Hence, we report a case of HOCM with ASD and 
PAPVC in a tertiary care hospital in India.
CASE REPORT
Informed consent was obtained from the patient. A 49-year-old 
male with HOCM was admitted to our hospital with complaints of 
gradually progressive breathlessness, angina, and exertional syncope. 
He had the history of systemic hypertension and bronchial asthma. 
He had undergone coronary angiogram 1 year before, which reveals 
a single vessel disease of ramus intermedius with 50% proximal 
stenosis and he was advised on medical management and surgical 
myectomy if symptoms persist. On physical examination, blood 
pressure was 133/88 mmHg, heart rate was 53 bpm. A 12-lead 
electrocardiogram revealed a left ventricular (LV) hypertrophy with 
strain pattern. Echocardiography showed features of hypertrophic 
obstructive cardiomyopathy, the presence of PAPVC, coronary artery 
disease (CAD), and a doubtful sinus venosus ASD. He had an LV peak 
pressure gradient of 60 mmHg, LV mid cavity, and apical gradients 
of 5-10 mmHg; LV apex showed increased hypertrophy with near 
systolic LV cavity, obliteration at mid-cavity and apex. Anteroseptum 
showed a thickness of 16-18 mm at the basal level and 18-22 mm at 
the mid-level, posterior wall had a thickness of 14 mm, inferoseptum 
demonstrated the thickness of 14 mm at the basal level and with 
thickness of 16 mm at the midlevel. Lateral wall thickness was found to 
be 13 mm, whereas inferior wall had a thickness of 13 mm and anterior 
wall of 14 mm. There was mild tricuspid regurgitation with increases 
pulmonary artery systolic pressure of 40 mmHg, mild functional mitral 
regurgitation (MR), minimal amount of pericardial effusion, and an 
adequate LV systolic function with an ejection fraction (EF) of 50-55% 
by three-dimensional echocardiography method.
Magnetic resonance imaging revealed a non-dilated LV with EF of 
76%, concentric hypertrophy with systolic arterial motion causing 
significant left ventricular outflow tract narrowing, patchy fibrosis in 
the hypertrophied segments, apical cavity obliteration and right PAPVC 
(Fig. 1). Laboratory analysis showed abnormal kidney function test with 
creatine (9 mg/dl) urea nitrogen (95.33 mL/min/1.73 cm2). All other 
parameters were normal. Patient has undergone a test for hepatitis B 
antigen, anti-hepatitis C virus antibody, and HIV (chemiluminescence) 
in which all showed negative results. Prescribed medications included 
tablet propranolol 40 mg thrice daily, atorvastatin 10 mg daily, aspirin 
75 mg daily, and amlodipine 5 mg daily.
Patient underwent transaortic and transventricular septal myectomy, 
PAPVC rerouting and ASD closure. In the procedure, midline sternotomy 
was done, thymus dissected, and pericardium opened. Heparin was 
given and went on bypass by bicaval cannulation and aortic cannulation. 
Cardioplegia was given through aortic root and heart was arrested 
in diastole. Right atrium was opened and using two-patch technique 
PAPVC rerouting and ASD closure was completed.
Using lazy “s” incision aorta opened and cardioplegia given through 
coronary ostia, septal myectomy was done transaortically. Apical 
hypertrophied part was addressed by opening the LV apex. Left ventricle 
was closed using hard Teflon buttressing the edge of LV opening. Aorta was 
also closed in two layers using 4-0 proline. De-airing was done through 
aortic root, and cross-clamp was released. Heart picked up in sinus rhythm 
without inotropic support. Hemostasis was achieved with protamine. 
Chest was closed after putting two mediastinal chest tubes and two right 
atrium and right ventricle pacing wires. Post-operative echocardiography 
showed no significant gradient across left ventricle outflow tract as well 
intracavitary gradients significantly came down with trivial MR, intact 
interventricular septum/inter arterial septum, good superior vena cava, 
and pulmonary vein (PV) flows. Gross examination of aortic soft tissue 
was studied for aortitis which gave no evidence of aortitis.
DISCUSSION
In 1971, Forker and Morgan [14] reported a case of idiopathic 
hypertrophic subaortic stenosis and an ostium secundum type ASD. 
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Hernández-Reyes et al. [15] described a 36-year-old patient with 
non-obstructive septal hypertrophy and ostium secundum ASD 
demonstrated by transthoracic echocardiography and confirmed by 
transesophageal echocardiography of the septal defect. Long et al. [16] 
reported a case with association of ostium secundum type ASD and 
sinus venous type ASD as a very rare form. Smith et al. [17] defined a 
case with similar association in a patient who was later operated and 
ASD closure and septal myomectomy were performed. Morito et al. [18] 
described a case of ASD in apical HOCM associated with coronary spasm 
in 2004.
HOCM has been reported to have some different associations. Branco 
et al. [19] reported a case with non-obstructive septal hypertrophy and 
ostium secundum type ASD who was diagnosed by transthoracic and 
transesophageal echocardiography, and the diagnosis was confirmed by 
cardiac catheterization, and the defect was closed surgically. However, 
the coexistence of hypertrophic obstructive cardiomyopathy, sinus 
venous ASD, PAPVC, and CAD is uncommon.
Partial anomalous pulmonary venous drainage occurs in about 10% 
of patients with atria, septal defect, whether this be a sinus venous 
type, a centrally situated secundum defect, or a large posterior 
defect with no posterior margin (pseudo-anomalous right PVs). The 
surgical anatomy of the sinus venous defect was first described in 
detail by Swan et al. [20] who recognized the absence of a posterior 
rim and upper margin and the association with partial anomalous 
pulmonary venous drainage. It was important to recognize 
the condition before operation since it made repair difficult, 
and cardiopulmonary bypass was always required to achieve a 
satisfactory result. The prevalence of SVD varies from 2% to 10% of 
patients with ASD [21,22].
In our case, the clinical symptoms of breathlessness and exertional 
syncope could be related to LV diastolic dysfunction as well as his 
hemodynamic instability created by HOCM and SVASD. The gradient 
in the mid-ventricular cavity might lead to decrease in cardiac output, 
and increased afterload, and reduced diastolic perfusion then could 
cause those symptoms of the patient. The syncope which precipitated 
on exertional was thought to be related with an infrequent interval of 
ventricular tachycardia, increase of mid-ventricular obstruction with 
exercise, and cerebral hypoperfusion.
CONCLUSION
Hence, whenever HOCM is proved in a patient, as it is a congenital 
anomaly, it is important to keep in mind that another accompanied 
congenital defect could be present.
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